Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Sales | 0 | 0 | 0 | 33 | 50 |
| Cost of Goods | 0 | N/A | 2,265 | 2,464 | 2,042 |
| Gross Profit | 0 | N/A | -2,265 | -2,431 | -1,992 |
| Operating Expenses | 1,890 | 0 | 265 | 464 | 42 |
| Operating Income | -1,890 | N/A | -2,265 | -2,431 | -1,992 |
| Interest Expense | 0 | 0 | 0 | 0 | 2 |
| Other Income | 250 | 0 | 179 | 283 | 329 |
| Pre-tax Income | -1,640 | 0 | -2,086 | -2,148 | -1,665 |
| Net Income Continuous | -1,648 | -2,075 | -2,086 | -2,148 | -1,665 |
| Net Income | $-1,648 | $-2,075 | $-2,086 | $-2,148 | $-1,665 |
| EPS Basic Total Ops | -3,250.00 | -5,000.00 | -4,250.00 | -4,250.00 | -2,500.00 |
| EPS Basic Continuous Ops | -3,250.00 | -5,000.00 | -4,250.00 | -4,250.00 | -2,500.00 |
| EPS Diluted Total Ops | -0.65 | -1.00 | -0.85 | -0.85 | -0.50 |
| EPS Diluted Continuous Ops | -3,296.00 | -5,187.50 | -4,172.00 | -4,296.00 | -3,330.00 |
| EBITDA(a) | $-1,870 | $N/A | $-2,265 | $-2,431 | $-1,992 |